# Tvardi Therapeutics, Inc.: Form 10-K for the period ended Dec 31, 2025

- Company: [Tvardi Therapeutics, Inc.](/companies/tvrd.md) (CIK 1346830)
- Form: 10-K
- Filed: 2026-03-31
- Accepted by EDGAR: Mar 31, 2026, 16:10 ET
- Period: 2025-12-31
- Accession: 0001104659-26-037729
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1346830/000110465926037729/tvrd-20251231x10k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1346830/000110465926037729/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 12 months, 2025-01-01 to 2025-12-31 | $18.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2025-01-01 to 2025-12-31 | −$26.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2025-01-01 to 2025-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | −$18.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2025-01-01 to 2025-12-31 | −$3.26 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2025-01-01 to 2025-12-31 | −$2.46 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2025-01-01 to 2025-12-31 | 7,783,182 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | −$23.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2025-12-31 | $20.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-12-31 | $31.5m | us-gaap:AssetsCurrent |
| Total assets | at 2025-12-31 | $32.1m | us-gaap:Assets |
| Current liabilities | at 2025-12-31 | $11.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-12-31 | $11.1m | us-gaap:Liabilities |
| Shareholders' equity | at 2025-12-31 | $20.9m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1346830/000110465926037729/tvrd-20251231x10k.htm

Filed Mar 31, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-037729. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.